| Primary |
| Thalassaemia Beta |
24.5% |
| Iron Overload |
11.6% |
| Hypertension |
10.9% |
| Chelation Therapy |
7.5% |
| Renal Failure |
5.4% |
| Congestive Cardiomyopathy |
3.4% |
| Iron Deficiency |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Anaemia |
2.7% |
| Analgesia |
2.7% |
| Blood Cholesterol Increased |
2.7% |
| Blood Folate Decreased |
2.7% |
| Blood Phosphorus Increased |
2.7% |
| Gastritis |
2.7% |
| Hyperparathyroidism |
2.7% |
| Serum Ferritin Decreased |
2.7% |
| Vitamin Supplementation |
2.7% |
| Prophylaxis |
2.0% |
| Thalassaemia |
2.0% |
| Haemochromatosis |
1.4% |
|
| Fundoscopy Abnormal |
17.9% |
| Visual Acuity Reduced |
14.3% |
| Cardiac Failure |
7.1% |
| Normal Newborn |
5.4% |
| Premature Baby |
5.4% |
| Therapeutic Response Decreased |
5.4% |
| Zygomycosis |
5.4% |
| Drug Exposure During Pregnancy |
3.6% |
| Failed Induction Of Labour |
3.6% |
| Foetal Distress Syndrome |
3.6% |
| Foetal Growth Retardation |
3.6% |
| Maculopathy |
3.6% |
| Medication Error |
3.6% |
| Renal Injury |
3.6% |
| Respiratory Disorder |
3.6% |
| Transplant Rejection |
3.6% |
| Arrhythmia |
1.8% |
| Cardiac Siderosis |
1.8% |
| Cardiomegaly |
1.8% |
| Cholestasis |
1.8% |
|
| Secondary |
| Hypertension |
18.8% |
| Renal Failure |
9.4% |
| Iron Overload |
8.8% |
| Anaemia |
5.3% |
| Thalassaemia Beta |
5.3% |
| Analgesia |
4.7% |
| Blood Cholesterol Increased |
4.7% |
| Blood Folate Decreased |
4.7% |
| Blood Phosphorus Increased |
4.7% |
| Gastritis |
4.7% |
| Hyperparathyroidism |
4.7% |
| Iron Deficiency |
4.7% |
| Serum Ferritin Decreased |
4.7% |
| Vitamin Supplementation |
4.7% |
| Stem Cell Transplant |
2.9% |
| Chelation Therapy |
1.8% |
| Haemochromatosis |
1.8% |
| Drug Use For Unknown Indication |
1.2% |
| Hepatitis C |
1.2% |
| Myelodysplastic Syndrome |
1.2% |
|
| Therapeutic Response Decreased |
12.9% |
| Transplant Rejection |
12.9% |
| Hepatitis B |
9.7% |
| Septic Shock |
6.5% |
| Serum Ferritin Increased |
6.5% |
| Zygomycosis |
6.5% |
| Brain Death |
3.2% |
| Glucose Tolerance Impaired |
3.2% |
| Hepatic Neoplasm |
3.2% |
| Hepatic Neoplasm Malignant |
3.2% |
| Maculopathy |
3.2% |
| Normal Newborn |
3.2% |
| Photosensitivity Reaction |
3.2% |
| Pulmonary Hypertension |
3.2% |
| Skin Reaction |
3.2% |
| Splenomegaly |
3.2% |
| Supraventricular Extrasystoles |
3.2% |
| Vestibular Disorder |
3.2% |
| Weight Increased |
3.2% |
| White Blood Cell Count Increased |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.1% |
| Bone Marrow Conditioning Regimen |
8.3% |
| Infection Prophylaxis |
7.8% |
| Prophylaxis Against Graft Versus Host Disease |
7.3% |
| Aplastic Anaemia |
6.8% |
| Prophylaxis |
6.8% |
| Iron Overload |
6.3% |
| Pain |
6.3% |
| Paroxysmal Nocturnal Haemoglobinuria |
4.4% |
| Myelodysplastic Syndrome |
3.9% |
| Premedication |
3.9% |
| Aspergillosis |
3.4% |
| Candidiasis |
3.4% |
| Lung Infection |
3.4% |
| Meningitis |
3.4% |
| Haematopoietic Stem Cell Mobilisation |
2.9% |
| Constipation |
2.4% |
| Sickle Cell Anaemia |
2.4% |
| Stem Cell Transplant |
2.4% |
| Waldenstrom's Macroglobulinaemia |
2.4% |
|
| Oesophagitis Ulcerative |
8.8% |
| Pulmonary Hilum Mass |
8.8% |
| Sepsis |
8.8% |
| Blood Iron Increased |
5.9% |
| Death |
5.9% |
| Interstitial Lung Disease |
5.9% |
| Pancytopenia |
5.9% |
| Septic Shock |
5.9% |
| Serum Ferritin Increased |
5.9% |
| Transplant Failure |
5.9% |
| Vomiting |
5.9% |
| Cardiac Arrest |
2.9% |
| Cerebral Infarction |
2.9% |
| Cerebral Ischaemia |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Chest Pain |
2.9% |
| Constipation |
2.9% |
| Erythema |
2.9% |
| Haemoglobin Abnormal |
2.9% |
| Haemolysis |
2.9% |
|
